7: No. 4, July 2010
Suggested citation for this article: Grant WB. The prevalence of multiple sclerosis in 3 US communities: the role of vitamin D [letter]. Prev Chronic Dis 2010;7(4):A89.
http://www.cdc.gov/pcd/issues/2010/jul/10_0066.htm. Accessed [date].
To the Editor:
Authors of the recent article on the prevalence of multiple sclerosis (MS) in 3 US communities (1) presented excellent findings but stumbled on their interpretation. The article noted that the findings were similar to those in a study of MS prevalence from the 1940s and 1950s (2); however, the authors did not make a detailed comparison with those data. Furthermore, the authors noted that UV radiation could explain the findings but did not suggest a mechanism for the link.
The data in reference 2 have been analyzed in previous studies, which found the distribution of MS in the United States to be well described by a quadratic fit to latitude (3). This fit is related to wintertime solar UVB (4). Winter is the season with the lowest levels of serum 25-hydroxyvitamin D in humans and the highest rate of viral infections (4). In a comparison of the prevalence data from reference 1 with those from reference 2, the recent data indicate a prevalence of approximately 7
cases per 100,000 per year less but with the same functional fit (Figure). The quadratic fit to the data in reference 2 explains 75% of the variance.
Figure. Prevalence of multiple sclerosis (MS) by latitude in the United States according to data from reference 1 (×) and reference 2 (o). The dashed line is a quadratic fit to the data in reference 1, and the solid line is a fit to the data in reference 2.
The most likely role of UVB in reducing risk of MS is through production of vitamin D. The Epstein-Barr virus has strong support as a possible risk factor for MS, as does vitamin D in reducing risk (5). Progress is being made in understanding the mechanisms by which vitamin D reduces the risk of MS (6). Among its other beneficial properties, vitamin D strengthens the innate immune system by inducing production of cathelicidin and defensins, both of which have antimicrobial and antiendotoxin
Given that the role of vitamin D in reducing the risk of MS was first
described in 1974 (4), it is disappointing that recommendations to increase
serum 25-hydroxyvitamin D levels, especially in winter, have not been made more
forcefully by US, European, and Australian health officials. The Institute of
Medicine of the National Academies is scheduled to announce new dietary
reference intakes for vitamin D and calcium in mid-2010 (www.iom.edu/Activities/Nutrition/DRIVitDCalcium.aspx),
so I hope this shortcoming will be rectified soon.
Back to top
The author receives funding from the UV Foundation (McLean, Virginia), the Sunlight Research Forum (Veldhoven, the Netherlands), and Bio-Tech-Pharmacal,
Inc (Fayetteville, Arkansas) and has previously received funding from the Vitamin D Society (Canada).
William B. Grant, PhD
Sunlight, Nutrition, and Health Research Center
San Francisco, California
Read the author’s reply
Back to top
- Noonan CW, Williamson DM, Henry JP, Indian R, Lynch SG, Neuberger JS, et al. The prevalence of multiple sclerosis in 3 US communities. Prev Chronic Dis 2010;7(1).
http://www.cdc.gov/pcd/issues/2010/jan/08_0241.htm. Accessed April 28, 2010.
- Wallin MT, Page WF, Kurtzke JF.
Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann Neurol 2004;55(1):65-71.
- Grant WB, Garland CF, Holick MF.
Comparisons of estimated economic burdens due to insufficient solar ultraviolet irradiance and vitamin D and excess solar UV irradiance for the United States. Photochem Photobiol 2005;81:1276-86.
- Grant WB.
Hypothesis — ultraviolet-B irradiance and vitamin D reduce the risk of viral infections and thus their sequelae, including autoimmune diseases and some cancers. Photochem Photobiol 2008;84(2):356-65.
- Ascherio A, Munger K.
Epidemiology of multiple sclerosis: from risk factors to prevention. Semin Neurol 2008;28(1):17-28.
- Cantorna MT.
Vitamin D and multiple sclerosis: an update. Nutr Rev 2008;66(10 Suppl 2):S135-8.
Back to top